Levofloxacin (Levaquin): Uses, Warnings, and More

What is levofloxacin?

Levofloxacin is an active ingredient used in the treatment of various bacterial infections. The original content lists uses such as acute bacterial sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, complicated skin infection, cystitis, and prostatitis.

The product ingredient is levofloxacin hemihydrate. In the United States, brand names listed in the source include Levaquin and Levaquin Leva-Pak.

How levofloxacin works

Levofloxacin is a fluoroquinolone antibacterial agent. According to the source content, it acts on the DNA gyrase complex and topoisomerase IV, which are targets involved in bacterial DNA replication.

Therapeutic uses listed in the source

The original content describes adult treatment uses for:

• Pyelonephritis and complicated urinary tract infections
• Chronic bacterial prostatitis
• Uncomplicated cystitis
• Inhalational anthrax, including treatment and post-exposure prophylaxis
• Acute bacterial sinusitis
• Acute exacerbation of chronic bronchitis
• Community-acquired pneumonia
• Complicated skin and soft tissue infections

The source also notes that use should be considered when recommended antibacterials are inappropriate.

Dosage information from the original content

The following dosing examples were included in the source. They are shown here for reference only and should be verified in the official leaflet or by a healthcare professional.

The source notes that treatment should continue at least 48–72 hours after the patient remains fever-free or after bacterial eradication has been demonstrated.

How it is taken

Oral use

The tablets should be swallowed without chewing and with enough liquid. The source says they can be divided by slot to adjust dosage and taken during or between meals.

They should be taken at least 2 hours before or after iron or zinc salts, antacids containing magnesium or aluminum, didanosine formulations with aluminum or magnesium buffering agents, and sucralfate.

Intravenous use

The source states that infusion should be slow, with a minimum of 30 minutes for 250 mg and 60 minutes for 500 mg.

Contraindications listed in the source

• Hypersensitivity to levofloxacin or other quinolones
• Epilepsy
• History of tendon disorders related to fluoroquinolones
• Children or adolescents in the growth phase
• Pregnancy and lactation

Warnings and precautions

The original content includes several important warnings. These are summarized below for readability.

Key warnings

• Kidney failure may require dose adjustment.
• Methicillin-resistant S. aureus is probably resistant to levofloxacin.
• Local resistance of E. coli should be considered.
• For inhalational anthrax, the source advises consulting national and/or international consensus documents.
• There is a risk of tendinitis and tendon rupture, especially in older adults, people receiving higher doses, and those treated with corticosteroids.
• The source also warns about pseudomembranous colitis, hemolytic reactions in G6PDH deficiency, severe hypersensitivity reactions, severe skin reactions, blood sugar changes in diabetics, bleeding risk with vitamin K antagonists, psychotic reactions, and superinfection with non-sensitive microorganisms during prolonged treatment.

Additional cautions

• Use caution in people predisposed to seizures or taking drugs that lower the seizure threshold.
• Use caution in people with psychiatric illness or a history of psychotic reactions.
• Use caution in people at risk of QT interval prolongation.
• Not recommended in myasthenia gravis.
• Consult an ophthalmologist if vision worsens.
• Avoid UV or sun exposure.
• The source warns about rare but serious long-lasting adverse reactions affecting multiple body systems.
• There is also a warning about increased risk of aneurysm and aortic dissection, especially in older adults.
• For IV use, the recommended infusion time should be respected and the infusion interrupted if blood pressure drops suddenly.

Renal insufficiency and dose adjustment

The source advises caution and dose adjustment when creatinine clearance is 50 mL/min or less. It provides several adjustment schemes depending on the usual regimen. Because these details are individualized, they should be checked in the official product information or by a clinician/pharmacist.

Interactions with levofloxacin

• Absorption may be reduced by iron or zinc salts, antacids with aluminum and magnesium, and didanosine formulations with aluminum or magnesium buffering agents.
• Sucralfate may reduce bioavailability.
• Caution is advised with drugs that lower the seizure threshold, such as theophylline, fenbufen, and NSAIDs.
• Caution is advised with drugs that prolong the QT interval, including some antiarrhythmics, tricyclic antidepressants, macrolides, and antipsychotics.
• Renal clearance may be decreased by probenecid and cimetidine.
• Cyclosporine half-life may increase.
• PT/INR and/or bleeding may increase with vitamin K antagonists such as warfarin.
• IV perfusion should not be mixed with heparin or alkaline solutions such as sodium bicarbonate.
• The source notes possible false-positive opiate urine tests and false-negative tuberculosis bacteriological diagnosis.

Pregnancy and breastfeeding

The source lists levofloxacin as contraindicated in pregnancy and contraindicated during breastfeeding. It notes that human data are limited and that experimental data suggest a risk of injury to weight-bearing cartilage in developing organisms.

Effects on driving and using machines

Some adverse reactions, such as dizziness, vertigo, drowsiness, and visual disturbances, may affect concentration and reaction time. The source says this may create a risk when driving or using machinery.

Adverse reactions listed in the source

• Insomnia
• Headache and dizziness
• Diarrhea, vomiting, and nausea
• Increased liver enzymes such as ALT, AST, alkaline phosphatase, and GGT
• With intravenous use: phlebitis and reactions at the administration site such as pain and redness
• With systemic use: severe skin adverse reactions, tendon inflammation and rupture, and SIADH

What to verify in the official leaflet

If you are checking a levofloxacin product, it is useful to confirm the following in the official FDA medication guide or package insert:

• The exact indication for the specific product
• The correct dose and duration for the patient’s age and kidney function
• Whether tablets, oral solution, or IV infusion are being used
• Interaction timing with antacids, iron, zinc, and sucralfate
• Any product-specific warnings or administration instructions

FAQ

Sources and references

The original content states that the information was prepared using clinical and molecular information from medicines authorized and marketed in the United States under the Unique Ingredient Identifier (UNII) by the FDA Substance Registration System (SRS) and the United States Pharmacopeia (USP).

For product-specific details, consult the FDA medication guide and official drug information resources.